LensGen is a clinical stage ophthalmic medical device company headquartered in Irvine, California focused on restoring youthful vision to millions of cataract and presbyopia patients. With its innovative Juvene® fluid-optic intraocular lens the company aims to treat vision correction errors and provide spectacle independence to patients affected by cataracts and/or presbyopia.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/20/20 | $10,000,000 | Series B |
Hoya Corporation | undisclosed |
